Renflexis
NDC 78206-162, infliximab, injection, powder, lyophilized, for solution, from Organon LLC.
- Product NDC
- 78206-162
- Status
- Listed
- Labeler
- Organon LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761054
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/78206-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLIXIMAB100 mg/1
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 78206-162-01 | 78206016201 | 1 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dbf738c4-3fac-4422-a9d8-51d9c83a8789Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=78206-162
Use it
Look up 78206-162 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/78206-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 78206-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.